Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-23

Clinical Trial Update: Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder

View source ↗

Summary

A completed University of Michigan study investigates brain and genetic markers that predict sertraline treatment response in social anxiety disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoloft (sertraline)

Snippet

Sponsor: University of Michigan | Conditions: Anxiety Disorders | Status: COMPLETED